Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v6-EN
Language French English
Date Updated 2022-07-20 2022-07-20
Drug Identification Number 02401606 02401606
Brand name ZOLEDRONIC ACID - Z ZOLEDRONIC ACID - Z
Common or Proper name ZOLEDRONIC ACID - Z ZOLEDRONIC ACID - Z
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ZOLEDRONIC ACID ZOLEDRONIC ACID
Strength(s) 4MG 4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5ML 1LIVI 5ML 1LIVI
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-20 2022-07-20
Estimated end date 2022-07-22 2022-08-26
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments